Fortress Biotech, Inc. (FBIO)

NASDAQ: FBIO · Real-Time Price · USD

2.720

-0.040 (-1.45%)

Aug 4, 2026, 4:00 PM EDT - Market closed

Fortress Biotech Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	66.16	63.26	57.68	84.51	75.74	68.79
Revenue Growth	14.50%	9.69%	-31.76%	11.58%	10.11%	50.86%
Gross Profit	43.81	42.34	36.8	61.62	44.97	36.71
Operating Income	-55.64	-70.22	-110.38	-142.34	-203.56	-188.54
Net Income	127.77	-1.88	-55.89	-68.67	-94.61	-64.7
Earnings Per Share	3.17	-0.07	-2.69	-8.47	-15.97	-11.85
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Journey	64.68	61.86	56.13	79.18
Fortress	-	-	1.5	5.23
Avenue	-	1.4	-	-
Checkpoint	-	-	0.04	0.1
Total	66.16	63.26	57.68	84.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	255.84	79.38	57.26	80.93	178.27	305.74
Total Debt	53.63	67.22	75.34	85.59	120.75	66.84
Net Cash (Debt)	202.21	12.17	-18.07	-4.67	57.52	238.9
Net Cash Growth	1082.33%	-	-	-	-75.92%	52.23%
Net Cash Per Share	6.69	0.44	-0.87	-0.58	9.71	43.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	157.64	-65.78	-80.19	-128.23	-179.4	-116.54
Capital Expenditures	-	-	-	-0.06	-2.72	-4.57
Free Cash Flow	157.64	-65.78	-80.19	-128.29	-182.12	-121.11
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	66.22%	66.92%	63.80%	72.91%	59.37%	53.36%
Operating Margin	-84.10%	-111.00%	-191.38%	-168.43%	-268.76%	-274.08%
Pretax Margin	160.70%	-53.01%	-209.00%	-181.79%	-281.83%	-238.92%
Profit Margin	194.88%	-52.03%	-209.55%	-182.40%	-282.42%	-239.60%
FCF Margin	238.26%	-103.98%	-139.04%	-151.80%	-240.44%	-176.05%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	1.62	0.61	0.61	-	-	-
PS Ratio	1.37	1.81	0.98	0.54	0.96	3.69